Comparing US and EU Insider Trading Laws: The Martha Stewart Case

This presentation explores the Martha Stewart insider trading case from both US and EU perspectives. It outlines the case details, including FDA-related stock sales and subsequent US convictions, followed by an analysis of EU regulations like MAR and CSMAD. It contrasts how insider dealing is evaluated and penalized in the EU, where broader definitions and enforcement mechanisms might lead to alternative penalties. The discussion highlights regulatory nuances, emphasizing legal and procedural...